Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

The connection between obesity and thyroid cancer underscores the importance of maintaining a healthy weight. With scientific ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.